American International Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,880
Closed -$73.1K 1718
2024
Q1
$73.1K Sell
24,880
-214
-0.9% -$607 ﹤0.01% 2670
2023
Q4
$75K Sell
25,094
-101
-0.4% -$289 ﹤0.01% 2698
2023
Q3
$79.6K Buy
25,195
+896
+4% +$2.92K ﹤0.01% 2638
2023
Q2
$94K Buy
24,299
+1,293
+6% +$3.73K ﹤0.01% 2617
2023
Q1
$63.7K Buy
23,006
+459
+2% +$963 ﹤0.01% 2644
2022
Q4
$40.6K Sell
22,547
-82
-0.4% -$158 ﹤0.01% 2802
2022
Q3
$48K Buy
22,629
+320
+1% +$805 ﹤0.01% 2824
2022
Q2
$60K Buy
+22,309
New +$83K ﹤0.01% 2817

Other funds holding NAUT

American International Group's NAUT Position: Q2 2024 in Review

American International Group sold out of Nautilus Biotechnolgy (NAUT) in Q2 2024, closing a stake of 24,880 shares — an estimated $73.1K sold.

American International Group first reported a position in NAUT in Q2 2022 and held it in 8 quarters. The position peaked at $94K in Q2 2023. 77 funds tracked by Wall St. Rank hold NAUT as of Q2 2024.

  • American International Group reported no remaining Nautilus Biotechnolgy position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 24,880 Nautilus Biotechnolgy shares in Q2 2024, an estimated $73.1K.
  • American International Group first reported a position in Nautilus Biotechnolgy in Q2 2022 and held it in 8 quarters.
  • American International Group's Nautilus Biotechnolgy position peaked at $94K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.